期刊文献+

Sympathetic nervous system activation and heart failure:Current state of evidence and the pathophysiology in the light of novel biomarkers 被引量:14

下载PDF
导出
摘要 Heart failure(HF)is a complex clinical syndrome characterized by the activation of at least several neurohumoral pathways that have a common role in maintaining cardiac output and adequate perfusion pressure of target organs and tissues.The sympathetic nervous system(SNS)is upregulated in HF as evident in dysfunctional baroreceptor and chemoreceptor reflexes,circulating and neuronal catecholamine spillover,attenuated parasympathetic response,and augmented sympathetic outflow to the heart,kidneys and skeletal muscles.When these sympathoexcitatory effects on the cardiovascular system are sustained chronically they initiate the vicious circle of HF progression and become associated with cardiomyocyte apoptosis,maladaptive ventricular and vascular remodeling,arrhythmogenesis,and poor prognosis in patients with HF.These detrimental effects of SNS activity on outcomes in HF warrant adequate diagnostic and treatment modalities.Therefore,this review summarizes basic physiological concepts about the interaction of SNS with the cardiovascular system and highlights key pathophysiological mechanisms of SNS derangement in HF.Finally,special emphasis in this review is placed on the integrative and up-to-date overview of diagnostic modalities such as SNS imaging methods and novel laboratory biomarkers that could aid in the assessment of the degree of SNS activation and provide reliable prognostic information among patients with HF.
出处 《World Journal of Cardiology》 CAS 2020年第8期373-408,共36页 世界心脏病学杂志(英文版)(电子版)
  • 相关文献

参考文献2

二级参考文献89

  • 1Beigi F, Bertucci C, Zhu W, Chakir K, Wainer IW, Xiao RP, et al.Enantioselective separation and online affinity chromatographic characterization of R,R- and S,S-fenoterol. Chirality 2006; 18: 822-7.
  • 2Jozwiak K, Khalid C, Tanga MJ, Berzetei-Gurske I, Jimenez L, Kozocas JA, et al. Comparative molecular field analysis of the binding of the stereo isomers of fenoterol and fenoterol derivatives to the β2 adrenergic receptor. J Med Chem 2007; 50: 2903-15.
  • 3Woo AY, Wang TB, Zeng X, Zhu W, Abernethy DR, Wainer IW, et al. Stereochemistry of an agonist determines coupling preference of 132-adrenoceptor to different G proteins in cardiomyocytes. Mol Pharmacol 2009; 75: 158-65.
  • 4Seifert R, Dove S. Functional selectivity of GPCR ligand stereoisomers: new pharmacological opportunities. Mol Pharmacol 2009; 75: 13-8.
  • 5Jozwiak K, Woo AY, Tanga MJ, Toll L, Jimenez L, Kozocas JA, et al. Comparative molecular field analysis of fenoterol derivatives: A platform towards highly selective and effective β2-adrenergic receptor agonists. Bioorg Med Chem 2010; 18: 728-36.
  • 6Talan MI, Ahmet I, Xiao RP, Lakatta EG. β2AR in the treatment of congestive heart failure: long path to translation. J Mol Cell Cardiol 2011; 51: 529-33.
  • 7Mangmool S, Shukla AK, Rockman HA. I3-Arrestin-dependent activation of Ca^2+/calmodulin kinase II after 131-adrenergic receptor stimulation. J Cell Biol 2010; 189: 573-87.
  • 8Zhu W, Woo AY, Yang D, Cheng H, Crow MT, Xiao RP. Activation of CaMKlloC is a common intermediate of diverse death stimuli-induced heart muscle cell apoptosis. J Biol Chem 2007; 282: 10833-9.
  • 9Ling H, Zhang T, Pereira L, Means CK, Cheng H, Gu y, et al. Requirement for Ca^2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice. J Clin Invest 2009; 119: 1230-40.
  • 10Van Oort RJ, McCauley MD, Dixit SS, Pereira L, Yang Y, Respress JL, et al. Ryanodine receptor phosphorylation by calcium/calmodulindependent protein kinase" promotes life-threatening ventricular arrhythmias in mice with heart failure. Circulation 2010; 122: 2669- 79.

共引文献34

同被引文献84

引证文献14

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部